Derya Unutmaz has received his Medical Degree from Marmara University Medical School, Istanbul, Turkey. He did postdoctoral studies at Novartis, Switzerland and at New York University (NYU) School of Medicine in NY. He was an assistant professor at Vanderbilt University, where he received tenure and promoted to associate professor. In 2006, he moved to NYU School of Medicine as tenured Professor of Microbiology, Medicine and Pathology. Since 2015 he has been Professor at Jackson Laboratory for Genomic Medicine, in Farmington, CT, and affiliated Professor at UConn School of Medicine. He is currently the director of Collaborative Research Center for ME/CFS at Jackson Laboratory. His lab developed various genetic methods and assays to interrogate human immune cells from healthy people and patients. These approaches led to several important discoveries in diseases such as HIV infection and cancer immunotherapy. His lab is also developing 3D-bioprinting and synthetic bioengineering technologies for precision medicine approaches for cancer and to fine-tune immune responses during aging and chronic diseases most recently of ME/CFS disease. His lab has also contributed to understanding of immune response to COVID-19 during the pandemic. He has published more than 130 original papers, including in top journals like Nature and Science, and is a co-inventor in 8 patents. His publications have received close to 25,000 citations and currently has H index of 66. He was also the Immunology section editor of PLoS One journal, section editor in Frontier’s in immunology and frequent reviewer of other journals. He also served as reviewer in more than 50 National Institute of Health (NIH) study sections and international review committees.